Keratoconus market
Sep 04, 2020
Keratoconus – Rare? Not really!
The Keratoconus market will be dominated by lenses, cross-linking procedures as well as IVMED-80, if approved in the coming decade. Keratoconus, away from the general perception of a rare disease, has come a long way. Thirty-four years back, in Minnesota, United States, this disease was claimed as rare, which cr...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
